Back to Search Start Over

Deceased-donor lobar lung transplant: A successful strategy for small-sized recipients.

Authors :
Campo-Canaveral De La Cruz, Jose Luis
Dunne, Ben
Lemaitre, Philippe
Rackauskas, Mindaugas
Pozniak, Jiri
Watanabe, Yui
Mariscal, Andrea
Yeung, Jonathan
Yasufuku, Kazuhiro
Pierre, Andrew
de Perrot, Marc
Waddell, Thomas K.
Cypel, Marcelo
Keshavjee, Shaf
Donahoe, Laura
Source :
Journal of Thoracic & Cardiovascular Surgery; May2021, Vol. 161 Issue 5, p1674-1685, 12p
Publication Year :
2021

Abstract

Lobar lung transplantation (LLTx) from deceased donors is a potential solution for donor–recipient size mismatch for small sized recipients. We reviewed our institutional experience to compare outcomes after LLTx to standard lung transplantation (LTx). We retrospectively reviewed transplants in our institution from January 2000 to December 2017. LLTx early- and long-term outcomes were compared with LTx. Additional analysis of outcomes was performed after dividing the cohort into 2 eras (era 1, 2000-2012; era 2, 2013-2017). Among the entire cohort (1665), 75 were LLTx (4.5%). Compared with LTx, LLTx were more frequently bridged to transplant with extracorporeal life support or mechanical ventilation and were transplanted in a rapidly deteriorating status (respectively, 20% vs 4.4%, P =.001; 22.7% vs 7.9, P <.001; and 41.3% vs 26.5%, P =.013). LLTx had longer intensive care unit and hospital lengths of stay (respectively, median 17 vs 4 days, and 45 vs 23, both P <.001), and greater 30-day mortality (13.3% vs 4.3%, P =.001) and 90-day mortality (17.3% vs 7.2%, P =.003). In era 2, despite a significantly greater 30-day mortality (10.8% vs 2.8%, P =.026), there was no significant difference in 90-day mortality between LLTx and LTx (13.5% vs 5.1%, P =.070). Overall survival at 1, 3, and 5 years was not significantly different between LLTx and LTx (73.2% vs 84.4%, 56.9% vs 68.4% and 50.4% vs 55.8, P =.088). Although LLTx is a high-risk procedure, both mid- and long-term survival are comparable with LTx in all cohorts in the modern era. LLTx therefore represents a valuable surgical option for small-sized recipients. Lobar lung transplant should be considered a valid option for pediatric and small-sized recipients, as they have longer times on the waiting list. Survival has improved in the modern era, with equivalent 90-day and long-term survival when compared with standard bilateral lung transplant. [Display omitted] [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00225223
Volume :
161
Issue :
5
Database :
Supplemental Index
Journal :
Journal of Thoracic & Cardiovascular Surgery
Publication Type :
Academic Journal
Accession number :
149779693
Full Text :
https://doi.org/10.1016/j.jtcvs.2020.04.166